OrbiMed Capital GP VI LLC
CIK 0001682115 Name as filed on the most recent filing
Filed as OrbiMed Capital GP VI LLC (83)
200 transaction lines · from 83 filings · filed 2017-04-27 to 2026-04-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Prelude Therapeutics Inc 3 filings
- ISSUER Adicet Bio, Inc. 5 filings
- ISSUER NeuroPace Inc 8 filings
- ISSUER Compass Therapeutics, Inc. 1 filings
- ISSUER Edgewise Therapeutics, Inc. 5 filings
- ISSUER Disc Medicine, Inc. 8 filings
- ISSUER ARS Pharmaceuticals, Inc. 4 filings
- ISSUER scPharmaceuticals Inc. 4 filings
- ISSUER Alpine Immune Sciences, Inc. 4 filings
- ISSUER Turnstone Biologics Corp. 1 filings
- ISSUER Verona Pharma plc 2 filings
- ISSUER SpringWorks Therapeutics, Inc. 9 filings
- ISSUER Ikena Oncology, Inc. 3 filings
- ISSUER 89bio, Inc. 3 filings
- ISSUER Oric Pharmaceuticals, Inc. 6 filings
- ISSUER CTI Biopharma Corp 1 filings
- ISSUER LogicBio Therapeutics, Inc. 2 filings
- ISSUER Graybug Vision, Inc. 1 filings
- ISSUER Prevail Therapeutics Inc. 1 filings
- ISSUER NextCure, Inc. 1 filings
- ISSUER Turning Point Therapeutics, Inc. 1 filings
- ISSUER SteadyMed Ltd. 2 filings
- ISSUER Constellation Pharmaceuticals Inc 1 filings
- ISSUER Kala Pharmaceuticals, Inc. 7 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-21 |
Prelude Therapeutics Inc PRLD |
P, Open-market purchase | 1,689,189 acquired | 4.44 | 7,499,999.16 | Form 4, filing 0000947871-26-000461 | |
| 2026-04-21 |
Prelude Therapeutics Inc PRLD |
P, Open-market purchase | 1,126,126 acquired | 4.44 | 4,999,999.44 | Form 4, filing 0000947871-26-000461 | |
| 2026-04-08 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 40,416 disposed | 6.52 | 263,512.32 | Form 4, filing 0000947871-26-000421 | |
| 2026-04-08 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 32,523 disposed | 6.29 | 204,569.67 | Form 4, filing 0000947871-26-000421 | |
| 2026-04-07 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 29,319 disposed | 6.53 | 191,453.07 | Form 4, filing 0000947871-26-000421 | |
| 2026-04-07 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 2,400 disposed | 6.38 | 15,312.00 | Form 4, filing 0000947871-26-000421 | |
| 2025-10-08 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 3,500,000 acquired | 1.00 | 3,500,000.00 | Form 4, filing 0000947871-25-000898 | |
| 2025-10-08 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 1,500,000 acquired | 1.00 | 1,500,000.00 | Form 4, filing 0000947871-25-000898 | |
| 2025-05-14 |
NeuroPace Inc NPCE |
S, Open-market sale | 134,136 disposed | 15.83 | 2,123,372.88 | Form 4, filing 0000947871-25-000548 | |
| 2025-05-14 |
NeuroPace Inc NPCE |
S, Open-market sale | 34,000 disposed | 15.94 | 541,960.00 | Form 4, filing 0000947871-25-000548 | |
| 2025-04-09 |
Compass Therapeutics, Inc. CMPX |
S, Open-market sale | 3,571,428 disposed | 1.59 | 5,678,570.52 | Form 4, filing 0000947871-25-000384 | |
| 2025-04-03 |
Edgewise Therapeutics, Inc. EWTX |
P, Open-market purchase | 372,578 acquired | 20.13 | 7,499,995.14 | Form 4, filing 0000947871-25-000359 | |
| 2025-04-03 |
Edgewise Therapeutics, Inc. EWTX |
P, Open-market purchase | 124,193 acquired | 20.13 | 2,500,005.09 | Form 4, filing 0000947871-25-000359 | |
| 2025-03-24 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 3,026 disposed | 54.11 | 163,736.86 | Form 4, filing 0000947871-25-000345 | |
| 2025-03-24 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 1,956 disposed | 54.11 | 105,839.16 | Form 4, filing 0000947871-25-000345 | |
| 2025-03-24 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 756 disposed | 54.11 | 40,907.16 | Form 4, filing 0000947871-25-000345 | |
| 2025-03-21 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 5,279 disposed | 54.00 | 285,066.00 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-21 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 3,412 disposed | 54.00 | 184,248.00 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-21 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 1,320 disposed | 54.00 | 71,280.00 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-20 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 1,457 disposed | 54.01 | 78,692.57 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-20 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 941 disposed | 54.01 | 50,823.41 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-20 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 364 disposed | 54.01 | 19,659.64 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-19 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 20,911 disposed | 54.02 | 1,129,612.22 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-19 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 13,517 disposed | 54.02 | 730,188.34 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-19 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 5,228 disposed | 54.02 | 282,416.56 | Form 4, filing 0000947871-25-000333 | |
| 2025-03-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 42,930 disposed | 54.44 | 2,337,109.20 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 27,750 disposed | 54.44 | 1,510,710.00 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 10,733 disposed | 54.44 | 584,304.52 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 933 disposed | 55.05 | 51,361.65 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 603 disposed | 55.05 | 33,195.15 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-12 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 233 disposed | 55.05 | 12,826.65 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-11 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 14,267 disposed | 54.01 | 770,560.67 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-11 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 9,222 disposed | 54.01 | 498,080.22 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-11 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 3,567 disposed | 54.01 | 192,653.67 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-10 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 106,384 disposed | 54.29 | 5,775,587.36 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-10 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 68,766 disposed | 54.29 | 3,733,306.14 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-10 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 26,596 disposed | 54.29 | 1,443,896.84 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-10 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 211 disposed | 55.01 | 11,607.11 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-10 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 136 disposed | 55.01 | 7,481.36 | Form 4, filing 0000947871-25-000308 | |
| 2025-03-10 |
Disc Medicine, Inc. IRON |
S, Open-market sale | 53 disposed | 55.01 | 2,915.53 | Form 4, filing 0000947871-25-000308 | |
| 2024-08-26 |
ARS Pharmaceuticals, Inc. SPRY |
S, Open-market sale | 83,695 disposed | 13.00 | 1,088,035.00 | Form 4, filing 0000947871-24-000728 | |
| 2024-08-23 |
ARS Pharmaceuticals, Inc. SPRY |
S, Open-market sale | 69,500 disposed | 13.03 | 905,585.00 | Form 4, filing 0000947871-24-000720 | |
| 2024-08-22 |
ARS Pharmaceuticals, Inc. SPRY |
S, Open-market sale | 391,482 disposed | 12.94 | 5,065,777.08 | Form 4, filing 0000947871-24-000720 | |
| 2024-08-21 |
ARS Pharmaceuticals, Inc. SPRY |
S, Open-market sale | 394,400 disposed | 13.52 | 5,332,288.00 | Form 4, filing 0000947871-24-000720 | |
| 2024-08-21 |
ARS Pharmaceuticals, Inc. SPRY |
S, Open-market sale | 13,300 disposed | 14.61 | 194,313.00 | Form 4, filing 0000947871-24-000720 | |
| 2024-08-13 |
scPharmaceuticals Inc. SCPH |
P, Open-market purchase | 478,342 acquired | 4.00 | 1,913,368.00 | Form 4, filing 0000947871-24-000701 | |
| 2024-08-13 |
scPharmaceuticals Inc. SCPH |
P, Open-market purchase | 21,658 acquired | 4.00 | 86,632.00 | Form 4, filing 0000947871-24-000701 | |
| 2024-06-17 |
Disc Medicine, Inc. IRON |
P, Open-market purchase | 43,944 acquired | 36.00 | 1,581,984.00 | Form 4, filing 0000947871-24-000573 | |
| 2024-06-17 |
Disc Medicine, Inc. IRON |
P, Open-market purchase | 28,404 acquired | 36.00 | 1,022,544.00 | Form 4, filing 0000947871-24-000573 | |
| 2024-06-17 |
Disc Medicine, Inc. IRON |
P, Open-market purchase | 10,986 acquired | 36.00 | 395,496.00 | Form 4, filing 0000947871-24-000573 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. OrbiMed Capital GP VI LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001682115
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6